NDC 63323-412-06 - Midazolam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-412
- Requested NDC
- 63323-412-06
- Package NDCs from labels
- 63323-412-00, 63323-412-18, 63323-412-25, 63323-412-03, 63323-412-02, 63323-412-06, 63323-412-05, 63323-412-13, 63323-412-10
- Manufacturer
- Fresenius Kabi USA, LLC
- Effective date
- 2025-11-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Midazolam - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2025-11-26 | HUMAN PRESCRIPTION DRUG LABEL |
| Midazolam - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2024-07-15 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-412-02 | Midazolam | 10 in 1 TRAY | INJECTION, SOLUTION | 10 | 7 | |
| 63323-412-03 | Midazolam | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | 7 | |
| 63323-412-05 | Midazolam | 10 in 1 TRAY | INJECTION, SOLUTION | 10 | 7 | |
| 63323-412-06 | Midazolam | 5 mL in 1 VIAL | INJECTION, SOLUTION | 5 | 7 | |
| 63323-412-10 | Midazolam | 10 in 1 TRAY | INJECTION, SOLUTION | 10 | 7 | |
| 63323-412-13 | Midazolam | 10 mL in 1 VIAL | INJECTION, SOLUTION | 10 | 7 | |
| 63323-412-18 | Midazolam | 1 mL in 1 VIAL | INJECTION, SOLUTION | 1 | 7 | |
| 63323-412-25 | Midazolam | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-412 | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 7 | Current NDC, Legacy NDC, 8 package rows | 20240806_a91ce254-14a3-4cbf-8ab8-5da252aa3fdc.zip |
| 63323-412 | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 3 | Current NDC, Legacy NDC | 20241031_09daf48f-1d44-4b7b-bb53-bd5635b93ca6.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-412-02 | ML - Milliliter | 63323-412 | 8efc1412-9341-407f-8f72-b8f5b766deea | 1 | 2013-02-13 |
| 63323-412-03 | ML - Milliliter | 63323-412 | 4b1d71cf-cbc3-4acf-b5f8-e874d80e51f0 | 1 | 2019-10-07 |
| 63323-412-05 | ML - Milliliter | 63323-412 | 882430ae-195a-4c1f-bcc3-4d84f685c3b9 | 1 | 2013-02-13 |
| 63323-412-06 | ML - Milliliter | 63323-412 | 1e201941-c71f-44ac-9e1f-fc7d13108905 | 1 | 2019-10-07 |
| 63323-412-10 | ML - Milliliter | 63323-412 | f3d9824f-c81d-4c0a-a1d5-19edfce62fc7 | 1 | 2013-02-13 |
| 63323-412-13 | ML - Milliliter | 63323-412 | ec1f0dac-d3c3-48d1-a934-beb19d3c6830 | 1 | 2019-10-07 |
| 63323-412-18 | ML - Milliliter | 63323-412 | 53679acb-42ac-40d1-a457-69fdf9d7a05c | 1 | 2019-10-07 |
| 63323-412-25 | ML - Milliliter | 63323-412 | d0d9cb42-66d0-4cd5-88dc-0bdf5e1dc61b | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| MIDAZOLAM HYDROCHLORIDE | ACTIVE INGREDIENT | W7TTW573JJ | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| MIDAZOLAM | ACTIVE MOIETY | R60L0SM5BC | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BM BIO28 (General Tonic) | CALC SULPH, CALC FLUOR, CALC PHOS, FERR PHOS, KALI MUR, KALI PHOS, KALI SULPH, MAG PHOS, NAT PHOS, NAT SULPH, NAT MUR, SILICEA | BM Private Limited | 38d2cff0-3550-b119-e063-6394a90a31cb | 2026-02-23 | Warnings | 451W47IQ8X |
| Allergy Kids | URTICA DIOICA LEAF, INULA HELENIUM ROOT, ANGELICA ARCHANGELICA ROOT, PINE NEEDLE OIL (PINUS SYLVESTRIS), SODIUM CHLORIDE, AND ALTHAEA OFFICINALIS ROOT | Forces of Nature | 4886109c-dd7d-40c0-911f-5f12343d8e63 | 2026-02-20 | Warnings | 451W47IQ8X |
| Allergy Maximum Strength | URTICA DIOICA, ALTHAEA OFFICINALIS ROOT, INULA HELENIUM ROOT, ANGELICA ARCHANGELICA ROOT, PINE NEEDLE OIL (PINUS SYLVESTRIS), SODIUM CHLORIDE, AND SILICON DIOXIDE | Forces of Nature | 122ca23e-43f1-4e5c-afc2-1418b1717679 | 2026-02-20 | Warnings | 451W47IQ8X |
| Back Pain Pain Management | ARNICA MONTANA, HORSE CHESTNUT, HYPERICUM PERFORATUM, RUTA GRAVEOLENS WHOLE, AND SODIUM CHLORIDE | Forces of Nature | bf089347-f334-4d6d-ab58-cf7f0b16810f | 2026-02-20 | Warnings | 451W47IQ8X |
| RHODODIUM | ACTEA RACEMOSA, APIS MELL, CALC CARB, GRAPHITES, IODIUM, NATRUM MUR, PULSATILLA, RHODODENDRON | BM Private Limited | 3b3bcba2-6f9e-cd94-e063-6394a90a7701 | 2026-02-15 | Warnings | 451W47IQ8X |
| Walgreens ULTRA FINE MOISTURIZING SALINE MIST | NASAL MIST | WALGREEN COMPANY | 48fef521-1b1d-d0d5-e063-6394a90ac7b1 | 2026-02-10 | Warnings | 451W47IQ8X |
| Walgreens SALINE MIST | NASAL MIST | WALGREEN COMPANY | 44815675-cc1d-a582-e063-6394a90ae8f6 | 2026-02-10 | Warnings | 451W47IQ8X |
| 0.9 percentsaline | SODIUM CHLORIDE | Huizhou Jinsheng Medical Technology Co., Ltd | 487cb4fc-2e0b-020f-e063-6294a90a4526 | 2026-02-03 | Warnings | 451W47IQ8X |
| 0.9saline | SODIUM CHLORIDE | Huizhou Jinsheng Medical Technology Co., Ltd | 49e76aca-ca2b-3b95-e063-6394a90a875e | 2026-02-03 | Warnings | 451W47IQ8X |
| 0.9%saline | SODIUM CHLORIDE | Huizhou Jinsheng Medical Technology Co., Ltd | 49e7b329-e4e5-6991-e063-6294a90ac817 | 2026-02-03 | Warnings | 451W47IQ8X |
| Adrenal Support | ADRENALINUM, BERBERIS VULGARIS, ARGENTUM NITRICUM, NATRUM MURIATICUM, VANADIUM METALLICUM, OLEUM MORRHUAE, PETROLEUM | NaturalCare | cee52757-a86e-4251-b65f-954ac85f4e7e | 2026-01-30 | Warnings | 451W47IQ8X |
| Vital Female Sexual Energy | AGNUS CASTUS, ARNICA MONTANA, AVENA SATIVA, CAULOPHYLLUM THALICTROIDES, CINCHONA OFFICINALIS, DAMIANA, HYPOPHYSIS SUIS, L-ARGININE, NATRUM MURIATICUM, OOPHORINUM SUIS, PHOSPHORICUM ACIDUM, SABAL SERRULATA, SEPIA, THUJA OCCIDENTALIS | Liddell Laboratories, Inc. | 7b15d6fa-eb04-41d2-8a01-6e7408ccf4d3 | 2026-01-30 | Warnings | 451W47IQ8X |
| Additive Formula 3 | DEXTROSE MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, SODIUM CHLORIDE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, CITRIC ACID MONOHYDRATE, AND ADENINE | Terumo BCT, Ltd | 9a5247a1-cc05-442d-b2d0-950f887f03c2 | 2026-01-30 | Warnings, Adverse reactions | 451W47IQ8X |
| CVS ULTRA FINE MOISTURIZING SALINE MIST | NASAL MIST | CVS | 44821c47-63f9-5d0a-e063-6394a90a555d | 2026-01-29 | Warnings | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Nephron Pharmaceuticals Corporation | a4edf2d5-a9ff-30d4-e053-2995a90a5650 | 2026-01-26 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | ProPharma Distribution | 48d73434-e65b-dc98-e063-6294a90affa2 | 2026-01-20 | Adverse reactions | 451W47IQ8X |
| Equate Comfort Flow Sinus wash | SINUS WASH | WALMART INC | 9e911eef-ca99-9902-e053-2a95a90aab0e | 2026-01-19 | Warnings | 451W47IQ8X |
| EQUATE PREMIUM SALINE | SODIUM CHLORIDE 0.65% | Walmart Stores, Inc. | 1e17f022-f513-140d-e063-6394a90a379e | 2026-01-19 | Warnings | 451W47IQ8X |
| Sodium chloride | SODIUM CHLORIDE | Fresenius Kabi USA, LLC | d98bf9f7-30ec-4927-a577-cabad192cb18 | 2026-01-19 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride Hypertonicity | SODIUM CHLORIDE | CVS Pharmacy | 9245d842-7f78-42d8-83ba-8eb9ec8dbc0d | 2026-01-15 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.